Interpreting overwhelming genetic results

Grand Rapids, Michigan, October 15, 2025 ⎯ Today, Sequencing.com (Sequencing), a biotech company offering the world's largest platform for whole genome sequencing and personalized health insights, announces a partnership with true. Women's Health, a concierge medical practice providing personalized care to women of all ages.

true. Women's Health focuses on midlife, menopause, sexual health, and weight management through a membership-based model. Now with Sequencing, their patients can gain insights into ~100% of their DNA test data and screen for almost all known health conditions, traits, and medication responses. Then, they can work with true. providers to translate that knowledge into clear, actionable steps for managing risks, optimizing wellness, and extending longevity.

Whole genome sequencing offers women deeper insight into their risk for heart disease, cancer, and metabolic conditions. For the first time, true. Women's Health will integrate DNA insights directly into personalized care plans for women navigating perimenopause and menopause. true. patients can take a test with one of Sequencing's custom kit bundles, which requires a simple cheek swab, and within weeks, they will have their results.

Dr. Celia Egan, MD, MSCP, DABOM, true. Women's Health Director of Obesity Medicine & Metabolic Health says, "Our vision is to offer a comprehensive framework for lifelong wellness through our programs. Many of our patients are interested in genetic tests but are rightfully nervous about choosing the appropriate one and understanding the results.

As a clinician, I shared that challenge. I needed a genetics test that could fit directly into our programs, but struggled to find reports that aligned with our pillars for easier patient understanding. Sequencing is the perfect solution."

Allyn Lebster, true. Women's Health President & Co-founder says, "Sequencing is working with us to provide a customized report bundle that maps directly to our wellness pillars, from metabolic health and cancer to bone density and emotional coping. This integration is the key. It finally allows us to guide patients in both test selection and result interpretation, turning complex genetic data into a clear, actionable part of their personalized health journey."

Dr. Brandon Colby, MD, Sequencing Founder & CEO, says, "true. Women's Health patients only need to be sequenced once, and from that single, definitive dataset, our platform becomes a permanent health resource, evolving alongside new scientific discoveries, medical research, and personal health goals. We're honored to partner with true. to better serve women and to tailor our sequencing service to align with their wellness programs."

This week, true. Women's Health hosted a public event for women to learn more about the new Sequencing partnership and to engage in whole genome sequencing themselves. Dr. Celia Egan shared how genomics fits into personalized healthcare, Sequencing walked patients through the science and the reports they will receive, and true. providers answered questions about how genetic testing can support midlife, menopause, and long-term health.

Importantly, Sequencing offers the most private DNA test on the market with HIPAA and US-EU-UK-Swiss Data Privacy Framework compliance. Testing is also performed in CLIA-certified, CAP-accredited clinical sequencing laboratories in the United States.

Learn more about this partnership at https://truewomenshealth.com/sequencing/.

About Sequencing.com

Founded by Dr. Brandon Colby, MD, Sequencing.com (Sequencing) is a U.S. biotech company offering whole genome sequencing that unlocks the most complete view of DNA. Most DNA tests allow users to gain insight into less than 0.1% of their DNA data, but Sequencing allows users to obtain ~100%. The company screens for almost all known health conditions, traits, and medication responses, then translates that knowledge into clear, actionable steps for managing risks, optimizing wellness, and extending longevity. The platform continuously reanalyzes information throughout a person's life, evolving alongside new scientific discoveries, medical research, and personal health goals. Sequencing offers the most private DNA test on the market with HIPAA and US-EU-UK-Swiss Data Privacy Framework compliance. Their whole genome sequencing is performed in CLIA-certified, CAP-accredited clinical sequencing laboratories in the U.S. To learn more about Sequencing, please visit Sequencing.com and LinkedIn.

About true. Women's Health About True Women's Health (true.)

true. Women's Health® is a Grand Rapids-based concierge medicine practice dedicated to women's health across all stages of life. Specializing in midlife, menopause, sexual health, lifestyle medicine, and weight management, true. delivers personalized care that emphasizes prevention, education, and patient goals. Founded by nationally recognized menopause expert Dr. Diana Bitner, MD, MSCP, FACOG, and healthcare executive and attorney Allyn Lebster, true. is transforming how women experience healthcare in Michigan and beyond. Learn more at truewomenshealth.com.

Media Contact:

Amanda Bell PR Lead amanda@sequencing.com

SOURCE: https://sequencing.com/blog/post/sequencingcom-true-women%E2%80%99s-health-now-incorporates-whole-genome-sequencing-their-complete